Sachs David C. sold IBRX
February 10, 2026 · Form 4 insider transaction
Sachs David C. sold 42,643 shares of ImmunityBio, Inc. at $6.93 per share, a transaction worth $295.5K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
42,643
Price
$6.93
Total value
$295.5K
InsiderSachs David C.
Role—
CompanyImmunityBio, Inc. (IBRX)
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateFebruary 10, 2026
Filing dateFebruary 12, 2026
Shares owned after280,175
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On February 10, 2026, the reporting person's RSUs vested. The closing price of the Issuer's common stock on February 9, 2026 was the settlement price used to calculate the shares withheld.